Long-term survival and recurrence outcomes following surgery for distal rectal cancer
- PMID: 20552409
- PMCID: PMC3071558
- DOI: 10.1245/s10434-010-1119-8
Long-term survival and recurrence outcomes following surgery for distal rectal cancer
Abstract
Background: Treatment of distal rectal cancer remains clinically challenging and includes proctectomy and coloanal anastomosis (CAA) or abdominoperineal resection (APR). The purpose of this study is to evaluate operative and pathologic factors associated with long-term survival and local recurrence outcomes in patients treated for distal rectal cancer.
Methods: A retrospective consecutive cohort study of 304 patients treated for distal rectal cancer with radical resection from 1993 to 2003 was performed. Patients were grouped by procedure (CAA or APR). Demographic, pathologic, recurrence, and survival data were analyzed utilizing chi-square analysis for comparison of proportions. Survival analysis was performed using Kaplan-Meier method and log-rank test for univariate and Cox regression for multivariate comparison.
Results: The median tumor distance from the anal verge was 2 cm [interquartile range (IQR) 0.5-4 cm]. Margins were negative in all but four patients (one distal, 0.3%; three radial, 1%). The 5-year overall survival rate was 82% (88.6% stage pI, 80.5% stage pII, 67.9% stage pIII). Older age, advanced pathologic stage, presence of lymphovascular or perineural invasion, earlier treatment period, and APR surgery type were associated with worse survival on multivariate analysis. The 5-year local recurrence rate was 5.3% after CAA and 7.9% after APR (p = 0.33).
Conclusions: Low rates of local recurrence and good overall survival can be achieved after treatment of distal rectal cancer with stage-appropriate chemoradiation and proctectomy with CAA or APR. Sphincter preservation can be achieved even with distal margins less than 2 cm.
Figures
Similar articles
-
Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection.Ann Surg. 2009 Feb;249(2):236-42. doi: 10.1097/SLA.0b013e318195e17c. Ann Surg. 2009. PMID: 19212176
-
Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.Ann Surg. 2004 Aug;240(2):260-8. doi: 10.1097/01.sla.0000133185.23514.32. Ann Surg. 2004. PMID: 15273550 Free PMC article.
-
Surgical treatment of adenocarcinoma of the rectum.Ann Surg. 1998 Jun;227(6):800-11. doi: 10.1097/00000658-199806000-00003. Ann Surg. 1998. PMID: 9637543 Free PMC article.
-
Sphincter preservation in rectal cancer.Curr Treat Options Oncol. 2000 Dec;1(5):399-405. doi: 10.1007/s11864-000-0067-0. Curr Treat Options Oncol. 2000. PMID: 12057147 Review.
-
Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer.Surg Oncol. 2013 Jun;22(2):144-9. doi: 10.1016/j.suronc.2013.03.003. Epub 2013 Apr 13. Surg Oncol. 2013. PMID: 23591063 Review.
Cited by
-
Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer: A Multicenter Comparative Cross-Sectional Study with Rectal Preservation as Supported by Surgeon.World J Surg. 2019 Dec;43(12):3216-3223. doi: 10.1007/s00268-019-05128-2. World J Surg. 2019. PMID: 31410512
-
One to Two Cycles of Consolidation Chemotherapy With Capecitabine After Neoadjuvant Chemoradiotherapy Does Not Benefit Low-Risk Patients With Locally Advanced Middle-Low Rectal Cancer.Front Oncol. 2021 Sep 30;11:695726. doi: 10.3389/fonc.2021.695726. eCollection 2021. Front Oncol. 2021. PMID: 34660266 Free PMC article.
-
Advances in surgical management for locally recurrent rectal cancer: How far have we come?World J Gastroenterol. 2017 Jun 21;23(23):4170-4180. doi: 10.3748/wjg.v23.i23.4170. World J Gastroenterol. 2017. PMID: 28694657 Free PMC article. Review.
-
Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer.Ann Surg Oncol. 2011 Apr;18(4):989-96. doi: 10.1245/s10434-010-1218-6. Epub 2010 Dec 4. Ann Surg Oncol. 2011. PMID: 21132391 Free PMC article.
-
Evaluation of ctDNA in the Prediction of Response to Neoadjuvant Therapy and Prognosis in Locally Advanced Rectal Cancer Patients: A Prospective Study.Pharmaceuticals (Basel). 2023 Mar 10;16(3):427. doi: 10.3390/ph16030427. Pharmaceuticals (Basel). 2023. PMID: 36986526 Free PMC article.
References
-
- NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–50. - PubMed
-
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med. 2004;351:1731–40. - PubMed
-
- Kapiteijn E, Marijnen C, Negtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–46. - PubMed
-
- Law WL, Chu KW. Abdominoperineal resection is associated with poor oncologic outcome. Br J Surg. 2004;91:1493–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous